269 related articles for article (PubMed ID: 31357673)
1. Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design.
Hevey R
Biomimetics (Basel); 2019 Jul; 4(3):. PubMed ID: 31357673
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the Development of Glycomimetic Drug Candidates.
Hevey R
Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 30978966
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fluorine in Glycomimetic Drug Design.
Hevey R
Chemistry; 2021 Feb; 27(7):2240-2253. PubMed ID: 32901973
[TBL] [Abstract][Full Text] [Related]
4. From carbohydrate leads to glycomimetic drugs.
Ernst B; Magnani JL
Nat Rev Drug Discov; 2009 Aug; 8(8):661-77. PubMed ID: 19629075
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists.
Damalanka VC; Maddirala AR; Janetka JW
Expert Opin Drug Discov; 2021 May; 16(5):513-536. PubMed ID: 33337918
[No Abstract] [Full Text] [Related]
6. Glycomimetic drugs--a new source of therapeutic opportunities.
Magnani JL; Ernst B
Discov Med; 2009 Dec; 8(43):247-52. PubMed ID: 20040279
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of glycomimetics: Recent advances.
Tamburrini A; Colombo C; Bernardi A
Med Res Rev; 2020 Mar; 40(2):495-531. PubMed ID: 31361344
[TBL] [Abstract][Full Text] [Related]
8. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
9. Glycomimetics for the inhibition and modulation of lectins.
Leusmann S; Ménová P; Shanin E; Titz A; Rademacher C
Chem Soc Rev; 2023 Jun; 52(11):3663-3740. PubMed ID: 37232696
[TBL] [Abstract][Full Text] [Related]
10. Targeting Galectins With Glycomimetics.
Bertuzzi S; Quintana JI; Ardá A; Gimeno A; Jiménez-Barbero J
Front Chem; 2020; 8():593. PubMed ID: 32850631
[TBL] [Abstract][Full Text] [Related]
11. Defining the Specificity of Carbohydrate-Protein Interactions by Quantifying Functional Group Contributions.
Sood A; Gerlits OO; Ji Y; Bovin NV; Coates L; Woods RJ
J Chem Inf Model; 2018 Sep; 58(9):1889-1901. PubMed ID: 30086239
[TBL] [Abstract][Full Text] [Related]
12. What contributes to an effective mannose recognition domain?
Sager CP; Eriş D; Smieško M; Hevey R; Ernst B
Beilstein J Org Chem; 2017; 13():2584-2595. PubMed ID: 29259668
[TBL] [Abstract][Full Text] [Related]
13. Enhancing Potency and Selectivity of a DC-SIGN Glycomimetic Ligand by Fragment-Based Design: Structural Basis.
Medve L; Achilli S; Guzman-Caldentey J; Thépaut M; Senaldi L; Le Roy A; Sattin S; Ebel C; Vivès C; Martin-Santamaria S; Bernardi A; Fieschi F
Chemistry; 2019 Nov; 25(64):14659-14668. PubMed ID: 31469191
[TBL] [Abstract][Full Text] [Related]
14. Lectin antagonists in infection, immunity, and inflammation.
Meiers J; Siebs E; Zahorska E; Titz A
Curr Opin Chem Biol; 2019 Dec; 53():51-67. PubMed ID: 31470348
[TBL] [Abstract][Full Text] [Related]
15. A novel role for small molecule glycomimetics in the protection against lipid-induced endothelial dysfunction: Involvement of Akt/eNOS and Nrf2/ARE signaling.
Mahmoud AM; Wilkinson FL; Jones AM; Wilkinson JA; Romero M; Duarte J; Alexander MY
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3311-3322. PubMed ID: 27554845
[TBL] [Abstract][Full Text] [Related]
16. Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics.
Fernández-Tejada A; Cañada FJ; Jiménez-Barbero J
Chemistry; 2015 Jul; 21(30):10616-28. PubMed ID: 26095198
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of carbohydrates and glycomimetics in anticancer drug design.
Barchi JJ
Curr Pharm Des; 2000 Mar; 6(4):485-501. PubMed ID: 10788593
[TBL] [Abstract][Full Text] [Related]
18. (19)F NMR-Guided Design of Glycomimetic Langerin Ligands.
Wamhoff EC; Hanske J; Schnirch L; Aretz J; Grube M; Varón Silva D; Rademacher C
ACS Chem Biol; 2016 Sep; 11(9):2407-13. PubMed ID: 27458873
[TBL] [Abstract][Full Text] [Related]
19. The Interaction of Fluorinated Glycomimetics with DC-SIGN: Multiple Binding Modes Disentangled by the Combination of NMR Methods and MD Simulations.
Martínez JD; Infantino AS; Valverde P; Diercks T; Delgado S; Reichardt NC; Ardá A; Cañada FJ; Oscarson S; Jiménez-Barbero J
Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32759765
[TBL] [Abstract][Full Text] [Related]
20. Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization.
Langdon SR; Ertl P; Brown N
Mol Inform; 2010 May; 29(5):366-85. PubMed ID: 27463193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
